[DPHARMA] QoQ TTM Result on 31-Dec-2017 [#4]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
28-Feb-2018
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
31-Dec-2017 [#4]
Profit Trend
QoQ- 4.79%
YoY- 56.71%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
Revenue 495,341 484,882 477,940 467,987 429,767 394,690 354,464 24.96%
PBT 54,833 53,202 52,929 51,796 45,270 38,579 32,714 41.05%
Tax -9,793 -9,321 -9,746 -9,696 -5,416 -3,626 -5,098 54.46%
NP 45,040 43,881 43,183 42,100 39,854 34,953 27,616 38.51%
-
NP to SH 45,277 44,396 43,710 42,492 40,548 35,484 27,890 38.08%
-
Tax Rate 17.86% 17.52% 18.41% 18.72% 11.96% 9.40% 15.58% -
Total Cost 450,301 441,001 434,757 425,887 389,913 359,737 326,848 23.79%
-
Net Worth 501,487 209,983 206,429 479,809 474,230 463,071 463,071 5.45%
Dividend
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
Div 20,937 20,937 23,711 23,711 7,085 7,085 19,142 6.15%
Div Payout % 46.24% 47.16% 54.25% 55.80% 17.47% 19.97% 68.64% -
Equity
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
Net Worth 501,487 209,983 206,429 479,809 474,230 463,071 463,071 5.45%
NOSH 661,881 650,902 278,959 278,959 278,959 278,959 278,959 77.79%
Ratio Analysis
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
NP Margin 9.09% 9.05% 9.04% 9.00% 9.27% 8.86% 7.79% -
ROE 9.03% 21.14% 21.17% 8.86% 8.55% 7.66% 6.02% -
Per Share
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
RPS 75.07 173.19 171.33 167.76 154.06 141.49 127.07 -29.57%
EPS 6.86 15.86 15.67 15.23 14.54 12.72 10.00 -22.19%
DPS 3.17 7.50 8.50 8.50 2.54 2.54 6.86 -40.20%
NAPS 0.76 0.75 0.74 1.72 1.70 1.66 1.66 -40.56%
Adjusted Per Share Value based on latest NOSH - 278,959
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
RPS 51.49 50.41 49.68 48.65 44.68 41.03 36.85 24.95%
EPS 4.71 4.62 4.54 4.42 4.22 3.69 2.90 38.12%
DPS 2.18 2.18 2.46 2.46 0.74 0.74 1.99 6.26%
NAPS 0.5213 0.2183 0.2146 0.4988 0.493 0.4814 0.4814 5.44%
Price Multiplier on Financial Quarter End Date
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
Date 28/09/18 29/06/18 30/03/18 29/12/17 29/09/17 30/06/17 31/03/17 -
Price 1.23 1.30 2.80 2.53 2.20 2.25 2.31 -
P/RPS 1.64 0.75 1.63 1.51 1.43 1.59 1.82 -6.70%
P/EPS 17.93 8.20 17.87 16.61 15.14 17.69 23.10 -15.52%
EY 5.58 12.20 5.60 6.02 6.61 5.65 4.33 18.40%
DY 2.58 5.77 3.04 3.36 1.15 1.13 2.97 -8.95%
P/NAPS 1.62 1.73 3.78 1.47 1.29 1.36 1.39 10.73%
Price Multiplier on Announcement Date
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
Date 28/11/18 26/11/18 28/05/18 28/02/18 17/11/17 25/08/17 22/05/17 -
Price 1.07 1.08 3.35 2.97 2.20 2.03 2.32 -
P/RPS 1.43 0.62 1.96 1.77 1.43 1.43 1.83 -15.14%
P/EPS 15.59 6.81 21.38 19.50 15.14 15.96 23.20 -23.26%
EY 6.41 14.68 4.68 5.13 6.61 6.27 4.31 30.26%
DY 2.97 6.94 2.54 2.86 1.15 1.25 2.96 0.22%
P/NAPS 1.41 1.44 4.53 1.73 1.29 1.22 1.40 0.47%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment